Kristian Lundsgaard Kraglund

  • Consultant; MD, PhD
 

Publications 2025

Ryan SJ, Jørstad ØK, Skjelland M, Simonsen CZ, Bek T, Blauenfeldt RA, Ijäs P, Laitinen A, Khanevski AN, Krohn J, Rødahl E, Lemmens R, Demeestere J, Cassiman C, Nakstad I, Evensen K, Sandell T, Hamann S, Christensen LM, Rosenbaum S, Matijosaitis V, Zemaitiene R, Ellekjær H, Austeng D, Truelsen TC et al. (2025)
Tenecteplase in Central Retinal Artery Occlusion Study (TenCRAOS): Protocol for a randomized-controlled trial
Eur Stroke J, 23969873251344199 (in press)
DOI 10.1177/23969873251344199, PubMed 40509553

Publications 2024

Amundsen EK, Ihle-Hansen H, Kraglund KL, Hagberg G (2024)
Acute ischemic stroke and measurement of apixaban and rivaroxaban: an observational cohort implementation study
Res Pract Thromb Haemost, 8 (1), 102307
DOI 10.1016/j.rpth.2023.102307, PubMed 38314168

Publications 2020

Damsbo AG, Mortensen JK, Kraglund KL, Johnsen SP, Andersen G, Blauenfeldt RA (2020)
Prestroke Physical Activity and Poststroke Cognitive Performance
Cerebrovasc Dis, 49 (6), 632-638
DOI 10.1159/000511490, PubMed 33176308

Publications 2019

Damsbo AG, Kraglund KL, Buttenschøn HN, Johnsen SP, Andersen G, Mortensen JK (2019)
Serotonergic Regulation and Cognition after Stroke: The Role of Antidepressant Treatment and Genetic Variation
Cerebrovasc Dis, 47 (1-2), 72-79
DOI 10.1159/000498911, PubMed 30844812

Damsbo AG, Kraglund KL, Buttenschøn HN, Johnsen SP, Andersen G, Mortensen JK (2019)
Predictors for wellbeing and characteristics of mental health after stroke
J Affect Disord, 264, 358-364
DOI 10.1016/j.jad.2019.12.032, PubMed 32056772

Kraglund KL, Mortensen JK, Johnsen SP, Andersen G, Grove EL (2019)
Antiplatelet effects of citalopram in patients with ischaemic stroke: A randomized, placebo-controlled, double-blind study
Sci Rep, 9 (1), 20048
DOI 10.1038/s41598-019-56487-8, PubMed 31882732

Publications 2018

Kraglund KL, Mortensen JK, Damsbo AG, Modrau B, Simonsen SA, Iversen HK, Madsen M, Grove EL, Johnsen SP, Andersen G (2018)
Neuroregeneration and Vascular Protection by Citalopram in Acute Ischemic Stroke (TALOS)
Stroke, 49 (11), 2568-2576
DOI 10.1161/STROKEAHA.117.020067, PubMed 30355209

Mortensen JK, Kraglund KL, Johnsen SP, Mors O, Andersen G, Buttenschøn HN (2018)
The Serotonin Transporter Gene Polymorphisms and Risk of Ischemic Stroke
Cerebrovasc Dis, 45 (3-4), 187-192
DOI 10.1159/000488364, PubMed 29614501

Publications 2015

Kraglund KL, Mortensen JK, Grove EL, Johnsen SP, Andersen G (2015)
TALOS: a multicenter, randomized, double-blind, placebo-controlled trial to test the effects of citalopram in patients with acute stroke
Int J Stroke, 10 (6), 985-7
DOI 10.1111/ijs.12485, PubMed 25854537

Publications 2013

Kraglund KL, Husted SE, Modrau B, Grove EL (2013)
[Anticoagulant therapy in stroke patients]
Ugeskr Laeger, 175 (5), 265-8
PubMed 23369327

Publications 2011

Hansen AS, Kraglund KL, Fedosova NU, Esmann M (2011)
Bulk properties of the lipid bilayer are not essential for the thermal stability of Na,K-ATPase from shark rectal gland or pig kidney
Biochem Biophys Res Commun, 406 (4), 580-3
DOI 10.1016/j.bbrc.2011.02.094, PubMed 21352812